Prevention of Future Deaths reports · 2023

Audrey King

Regulation 28 report to prevent future deaths, reference 2023-0312, written 22 Aug 2023. A coroner writes one of these when an inquest reveals a risk that could cause further deaths unless something changes.

Date of report22 Aug 2023
Reference2023-0312
DeceasedAudrey King
CoronerGuy Davies
Coroner areaCornwall and the Isles of Scilly
CategoryHospital Death (Clinical Procedures and medical management) related deaths
Sourcejudiciary.uk record · original PDF
Responses published1

The report

Text extracted from the PDF text layer. Reproduced verbatim, including the scan's own layout.

Information Classification: PUBLIC 

REGULATION 28:  REPORT TO PREVENT FUTURE DEATHS  

IN THE MATTER OF THE INQUEST  

TOUCHING THE DEATH OF AUDREY KING 

REGULATION 28 REPORT TO PREVENT FUTURE DEATHS 

THIS REPORT IS BEING SENT TO: 

The Chief Executive Officer 
Royal Cornwall Hospital Trust (RCHT) 

1 

CORONER 

I am Guy Davies, His Majesty’s Assistant Coroner for Cornwall & the Isles of Scilly. 

2 

CORONER’S LEGAL POWERS 

I make this report under paragraph 7, Schedule 5, of the Coroners and Justice Act 2009 
and regulations 28 and 29 of the Coroners (Investigations) Regulations 2013. 
[HYPERLINKS] 

3 

INVESTIGATION and INQUEST 

On 21 November 2022 I commenced an investigation into the death of Audrey King. The 
investigation concluded at the end of the inquest on 7 August 2023. 

The medical cause of death was found as follows 

1a Ischaemic stroke 
1b Atrial Fibrillation  
II Femoral Hernia repair (Operated) 

The four questions - who, when, where and how – were answered as follows … 

Audrey KING died on 15 November 2022 at Royal Cornwall Hospital Truro 
Cornwall from a stroke following an operation, against a background of atrial 
fibrillation in which anti-coagulant medication was not re-started which likely 
contributed to the stroke. 

The conclusion was as follows 

Audrey died from complications following necessary surgery contributed to by 
not re-starting anti-coagulant medication after the operation. 

1 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Information Classification: PUBLIC 

4 

CIRCUMSTANCES OF THE DEATH 

Audrey had a previous medical history which included Atrial Fibrillation (AF), which was 
medicated by an anti-coagulant, apixaban, to reduce the risk of a stroke. 

On 6 November 2022, Audrey was admitted to RCHT with abdominal pain secondary to 
femoral hernia obstruction.  The apixaban was suspended pending surgery. Audrey 
underwent surgery for femoral hernia repair, that same day, 6 November 2022. The 
operation was uneventful. 

On 9 November 2022 the eldercare consultant reviewed Audrey.  The review notes were 
handwritten on paper medical notes. The eldercare consultant recommended that the 
surgical team restart Apixaban as soon as safe post operatively.  

The court heard evidence that the NICE guidance on this subject states 

Stroke risk associated with atrial fibrillation; Post procedure with immediate and 
complete haemostasis NOACs can generally be resumed 6–8 h after the end of 
the intervention. Some surgical interventions carry increased bleeding risk in 
which case resume anticoagulation 48–72 h post procedure but at the earliest 
opportunity 

The apixaban was not restarted. 

On 11 November 2022 Audrey had a severe stroke secondary to AF.  Audrey died as a 
result of this complication four days later. 

The court found that whether and when to re-start the apixaban was a decision for the 
surgical team.  The court heard that on the consultant surgeon’s ward round his junior 
doctor colleague was briefing him, this included reference to the eldercare review paper 
notes. The junior doctor went through a number of aspects regarding care and treatment 
but did not refer to the recommendation to re-start apixaban. As a result, the consultant 
surgeon did not consider whether or not to re-start the apixaban. 

The court heard that the eldercare team use paper medical notes whilst the surgical 
team use a digital system, known as NerveCentre.  The consultant surgeon stated that 
the digital system is easier for the surgical team to read because the consultant 
surgeons can look at the detail on their phone or iPad. The consultant surgeon 
considered that the different recording platforms contributed to the error of omission in 
Audrey’s case. 

Where an ‘important clinical note’ has been handwritten in the handwritten record there 
is facility for highlighting this on the ‘ward round’ function on Nerve centre. There was no 
alert that clinical notes had been handwritten in the written notes following the review by 
the eldercare consultant on 9th November. 

The court found that apixaban was prescribed on admission and correctly suspended 
due to bleeding risk in light of pending surgery. There is no evidence of review of this 
suspension in either medicines reconciliation (10th November) or in the medical records.  
The court heard that there is no automatic flag on the Electronic Prescribing Medication 
Administration (EPMA) requiring review of the ongoing suspension of prescribed 
medication. 

5 

CORONER’S CONCERNS 

During the course of the inquest the evidence revealed matters giving rise to concern. In 
my opinion there is a risk that future deaths will occur unless action is taken. In the 
circumstances it is my statutory duty to report to you. 

2 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Information Classification: PUBLIC 

The MATTERS OF CONCERN are as follows.  –  

(1) Inconsistencies in record keeping between specialities. 
(2) The process for entering an alert in the digital system that clinical notes have been 
handwritten in the written notes. 
(3) The absence of an alert on the EPMA requiring review of the ongoing suspension of 
prescribed medication. 

6 

ACTION SHOULD BE TAKEN 

In my opinion action should be taken to prevent future deaths and I believe you 
[AND/OR your organisation] have the power to take such action.  

7 

YOUR RESPONSE 

You are under a duty to respond to this report within 56 days of the date of this report, 
namely by 17 October 2023. I, the coroner, may extend the period. 

Your response must contain details of action taken or proposed to be taken, setting out 
the timetable for action. Otherwise, you must explain why no action is proposed. 

8 

COPIES and PUBLICATION 

I have sent a copy of my report to the Chief Coroner and to the family. 

I am also under a duty to send the Chief Coroner a copy of your response.  

The Chief Coroner may publish either or both in a complete or redacted or summary 
form. He may send a copy of this report to any person who he believes may find it useful 
or of interest. You may make representations to me, the coroner, at the time of your 
response, about the release or the publication of your response by the Chief Coroner. 

9 

Guy Davies 
HM Assistant Coroner for Cornwall & the Isles of Scilly 
22 August 2023                

3

Responses

1 response published against this report on judiciary.uk. A response is a body's written reply to the coroner's concerns; publication is at the discretion of the Chief Coroner's office, so an absent response does not mean nobody replied.

Response from Royal Cornwall Hospitals NHS Trust (PDF)
Chief Medical Officer’s Office 

Royal Cornwall Hospital 

Truro 

Cornwall  

TR1 3LJ 

12th October 2023 

Mr Guy Davies 
Assistant Coroner for Cornwall and the Isles of Scilly 
H.M Coroner’s Office 
Pydar House, Pydar Street 
Truro, Cornwall 
TR1 1XU 

Dear Mr Davies 

Re: Death of Audrey Joan King – Response to Regulation 28 Report to Prevent 
Future Deaths 

I write in response to the Regulation 28 Report to Prevent Future Deaths, dated 22nd August 
2023 and received on the 24th August 2023, which was issued at the end of the inquest into 
the death of Mrs Audrey Joan King on 7th August 2023. 

I would like to take this opportunity to express my sincerest condolences to the family of Mrs 
King for their loss.  

During the course of the inquest, the evidence revealed matters giving rise to concern. These 
are as follows: 

Inconsistencies in record keeping by specialities. 

• 
•  The  process for  entering  an  alert  in the  digital  system that  clinical  notes have  been 

handwritten in the written notes. 

•  The absence of an alert on the EPMA requiring review of the ongoing suspension of 

prescribed medication. 

Please  find  below  the response  from  the  Trust  and  the  detail  of the  actions  being  taken  in 
relation to each concern. 

1 

 
 
 
 
 
 
 
 
 
 
 
 Inconsistences in record keeping by specialities: 

I  note  that  the  Inquest  conclusion  was  that  ‘Audrey  died  from  complications  following 
necessary  surgery  contributed  to  by  not  re-starting  anti-coagulant  medication  after  the 
operation.’ 

, 
The clinical context that may have led to Mrs King’s death was discussed with 
Stroke Consultant. Mrs King was known to have atrial fibrillation (AF) and there is a known 
increased  risk  of  stroke  post-operatively.  There  were  clear  recommendations  which  were 
underlined in Mrs King’s notes by the care of the elderly consultant to re-start apixaban as 
soon as possible post-operatively. Unfortunately, these recommendations were not followed 
and could have been one of the factors leading to ischaemic stroke.  

The  Trust  is  moving  towards  having  all  clinical  records  available  electronically  and  Oracle 
Health have been awarded the contract for our Electronic Patient Record (EPR) programme. 
The new EPR will integrate many of our digital and paper-based systems into a single platform, 
providing  a  more  joined  up  way  of  working  across  our  hospitals,  improving  safety  and 
transforming the way we care. This system is expected to be operational from Spring 2025.  

Until this is underway, the Trust has taken the decision to advise all specialities to only record 
inpatient clinical entries in the written paper notes with the exception of EPMA (which is our 
electronic  prescribing  system).  The  only  ward  exceptions  to  this  are  ITU  /EPOC  (Intensive 
care and Enhanced peri-operative care unit) which have an electronic record and high staff to 
patient ratio, there is no duplication and a paper copy is transferred with the patient when they 
leave ITU/EPOC.  This will ensure all specialities undertaking ward rounds will have one set 
of  written  notes  to  review,  along  with  the  drugs  chart  (ePMA)  The  decision  to  revert  to 
recording in the written notes was communication to staff and took effect from 08:00 hours on 
13 September 2023. 

The  process  for  entering  an  alert  in  the  clinical  system  that  clinical  notes  have  been 
handwritten in the written notes: 

Please see above, as all specialities have been mandated to only record entries in the written 
notes, there is no requirement to set up an alert in a clinical system that a written entry has 
been made in the notes. 

The absence of an alert on the EPMA requiring review of the ongoing suspension of prescribed 
medication: 

The  Trust  currently  uses  Careflow  Medicines  Management  systems  to  support  electronic 
prescribing across most clinical areas.  This system does not have the capability to set up an 
alert  if  medications  are  suspended.    However,  even  if  this  was  an  option,  it  would  not  be 

2 

 
 
 
 
 
 
 
 
 
 considered of benefit due to prescriber alert fatigue which could lead to prescribers ignoring 
the  alert.  To  put  this  into  context,  for  example,  on  4th  September  2023,  9%  of  medications 
prescribed for inpatients in the hospital were suspended across the Trust. This equates to 636 
suspended items out of a total of 7,010 prescribed medicines for 706 patients.  

When a drug is suspended it remains on the inpatient chart, with an overlay showing that the 
drug is suspended (see chart below).  When opening the drug chart, the ePMA system gives 
a clear visual prompt during wards rounds that a current medicine is suspended and this can 
be re-started if appropriate.  Suspended drugs should be reviewed as part of the ward round 
drug chart review process.  

As advised above, the system does not have the ability to create a separate alert; however 
there is a clear visual prompt to alert clinicians that a drug has been suspended and this was 
in place and in force at the time of Mrs King’s admission. 

All doctors have a professional responsibility to check written entries, drugs charts and test 
results on a ward round to ensure they have the full facts before making any clinical decisions. 
The importance of this is clear in the GMC Guidance, ‘Good Medical Practice’ - Duties of a 
Doctor  and  provided  over  extensive  teaching  and  education  with  Foundation  Year  1  and  2 
doctors  and  IMG  induction.    The  Trust  will  also  run  Snapcoms  about  the  importance  of 
checking ePMA along with written entries which will be aimed all staff working within the Trust. 

I hope that this letter provides both you and Mrs King’s family with assurance that the Trust 
has taken seriously the matter of concerns you raised in your report.  

3 

 
 
 
 
 Yours Sincerely 

Chief Medical Officer 

4

Related reports

Other reports by Guy Davies

See all →

More reports categorised “Hospital Death (Clinical Procedures and medical management) related deaths”

See all →

Track Hospital Death (Clinical Procedures and medical management) related deaths

See every Prevention of Future Deaths report matching Hospital Death (Clinical Procedures and medical management) related deaths, and how often a new one appears.

What would an alert for this have sent me? Search the full text

Free to try — the preview shows the real matches and how many arrived in the last 12 months. Your first email alert is free.

These reports are published by the Chief Coroner's office at judiciary.uk and are © Crown copyright. The text here is reproduced from the published PDF so it can be searched. If something on this page is wrong, or you are a person named in it and want it reviewed, email drcjar@gmail.com and we will act promptly.